We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | 장 마감 후 (AMC) | $0.37 | — | — | $2.8B | — | 예정 |
| FY2026 Q1 | 2025. 03. 31. | 시각 미정 | — | $0.25 | — | — | $2.63B | 보고됨 |
| FY2025 Q3 | 2024. 09. 30. | 시각 미정 | — | $-0.27 | — | — | $7.88B |
Consensus PT $21.96 · 13 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 29. | Citigroup | — | 투자의견 하향 | Neutral → Sell | — | Citigroup: Neutral → Sell |
| 2026. 05. 04. | Barclays | — | 의견 유지 | Overweight → Overweight | — | Barclays: Overweight |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
| FY2025 Q2 | 2024. 06. 30. | 시각 미정 | — | $-0.54 | — | — | $5.18B | 보고됨 |
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
표시할 보유 데이터가 없습니다.
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Stored first · Google News · Yahoo Finance (English)
Citigroup Downgrades Baxter International to Sell From Neutral, Adjusts PT to $17 From $19 - Moomoo
Citigroup Downgrades Baxter International to Sell From Neutral, Adjusts PT to $17 From $19 Moomoo
Baxter International Stock Surges 12%, With A 6-Day Winning Spree - Trefis
Baxter International Stock Surges 12%, With A 6-Day Winning Spree Trefis
Baxter International Stock 6-Day Winning Spree: Stock Climbs 12% - Trefis
Baxter International Stock 6-Day Winning Spree: Stock Climbs 12% Trefis
Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump - Yahoo Finance
Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump Yahoo Finance